US 9512401
B and T lymphocyte attenuator marker for use in adoptive T-cell therapy
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 9512401 (B and T lymphocyte attenuator marker for use in adoptive T-cell therapy) held by The Board of Regents of the University of Texas System expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/57, A61K40/11